Catalyst Capital Advisors’s Amgen AMGN Stock Holding History

Catalyst Capital Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54K	Sell	149 -55	-27%	-$18.8K	﹤0.01%	288
2026 Q1	$71.8K	Buy	204 +21	+11%	+$7.49K	﹤0.01%	272
2025 Q4	$59.9K	Sell	183 -84	-31%	-$26.6K	﹤0.01%	315
2025 Q3	$75.3K	Sell	267 -59	-18%	-$17.1K	﹤0.01%	364
2025 Q2	$91K	Sell	326 -91	-22%	-$25.8K	﹤0.01%	349
2025 Q1	$130K	Buy	417 +3	+0.7%	+$886	﹤0.01%	273
2024 Q4	$108K	Hold	414	–	–	﹤0.01%	284
2024 Q3	$133K	Sell	414 -100	-19%	-$32.7K	﹤0.01%	255
2024 Q2	$161K	Buy	514 +11	+2%	+$3.23K	﹤0.01%	212
2024 Q1	$143K	Buy	+503	New	+$147K	﹤0.01%	209
2023 Q4	–	Sell	-395	Closed	-$106K	–	369
2023 Q3	$106K	Buy	395 +101	+34%	+$25.2K	﹤0.01%	212
2023 Q2	$65.3K	Sell	294 -14	-5%	-$3.25K	﹤0.01%	263
2023 Q1	$74.5K	Sell	308 -109	-26%	-$26.8K	﹤0.01%	240
2022 Q4	$110K	Sell	417 -10	-2%	-$2.68K	﹤0.01%	212
2022 Q3	$96K	Sell	427 -18	-4%	-$4.36K	﹤0.01%	228
2022 Q2	$108K	Buy	445 +56	+14%	+$13.7K	﹤0.01%	239
2022 Q1	$94K	Buy	389 +75	+24%	+$17.2K	﹤0.01%	268
2021 Q4	$71K	Sell	314 -27	-8%	-$5.7K	﹤0.01%	272
2021 Q3	$73K	Sell	341 -13	-4%	-$2.99K	﹤0.01%	282
2021 Q2	$86K	Buy	354 +12	+4%	+$2.95K	﹤0.01%	288
2021 Q1	$85K	Sell	342 -68	-17%	-$16.2K	﹤0.01%	267
2020 Q4	$94K	Buy	+410	New	+$94.5K	0.01%	260
2019 Q1	–	Sell	-113,685	Closed	-$22.1M	–	394
2018 Q4	$22.1M	Buy	113,685 +94,693	+499%	+$18.5M	0.83%	12
2018 Q3	$3.94M	Buy	18,992 +1,492	+9%	+$294K	0.13%	98
2018 Q2	$3.23M	Sell	17,500 -3,886	-18%	-$687K	0.11%	102
2018 Q1	$3.65M	Buy	21,386 +20,236	+1,760%	+$3.71M	0.13%	92
2017 Q4	$200K	Hold	1,150	–	–	0.01%	251
2017 Q3	$214K	Sell	1,150 -1,000	-47%	-$177K	0.01%	249
2017 Q2	$370K	Hold	2,150	–	–	0.02%	221
2017 Q1	$353K	Hold	2,150	–	–	0.02%	230
2016 Q4	$314K	Sell	2,150 -385	-15%	-$57.9K	0.02%	238
2016 Q3	$423K	Sell	2,535 -22,140	-90%	-$3.74M	0.05%	199
2016 Q2	$3.75M	Sell	24,675 -10,815	-30%	-$1.68M	0.69%	53
2016 Q1	$5.32M	Buy	35,490 +385	+1%	+$57.2K	0.9%	36
2015 Q4	$5.7M	Buy	35,105 +20,000	+132%	+$3.14M	0.83%	43
2015 Q3	$2.09M	Buy	15,105 +10,000	+196%	+$1.58M	0.28%	96
2015 Q2	$784K	Hold	5,105	–	–	0.09%	178
2015 Q1	$816K	Hold	5,105	–	–	0.09%	160
2014 Q4	$813K	Hold	5,105	–	–	0.1%	171
2014 Q3	$717K	Hold	5,105	–	–	0.09%	190
2014 Q2	$604K	Hold	5,105	–	–	0.1%	222
2014 Q1	$630K	Hold	5,105	–	–	0.14%	182
2013 Q4	$583K	Hold	5,105	–	–	0.19%	160
2013 Q3	$571K	Sell	5,105 -6,048	-54%	-$656K	0.31%	132
2013 Q2	$1.1M	Buy	+11,153	New	+$1.16M	0.85%	27

Other funds holding AMGN

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFM

Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Catalyst Capital Advisors's AMGN Position: Q2 2026 in Review

Catalyst Capital Advisors reduced its Amgen (AMGN) stake by 27% in Q2 2026, selling an estimated $18.8K and leaving 149 shares worth $54K. The position accounts for ﹤0.01% of the portfolio, ranked #288.

Catalyst Capital Advisors first reported a position in AMGN in Q2 2013 and has held it in 45 quarters since. The position peaked at $22.1M in Q4 2018. 1,171 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Catalyst Capital Advisors held 149 shares of Amgen worth $54K as of Q2 2026.
Catalyst Capital Advisors sold 55 Amgen shares in Q2 2026, an estimated $18.8K.
Amgen made up ﹤0.01% of Catalyst Capital Advisors's portfolio in Q2 2026, its #288 holding.
Catalyst Capital Advisors first reported a position in Amgen in Q2 2013 and has held it in 45 quarters since.
Catalyst Capital Advisors's Amgen position peaked at $22.1M in Q4 2018.
1,171 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Catalyst Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.